News

Welcome to the CLINUVEL News page. Discover the latest in clinical, corporate, and regulatory updates.

Form 604

2016 Announcements

18.03.2016

Form 604 – March 15, 2016

2016 Announcements

15.03.2016

CLINUVEL accredits first European EPP expert centres

2016 Announcements

13.03.2016

CLINUVEL placement of A$8.3 million completed successfully

2016 Announcements

13.03.2016

Request for Trading Halt

2016 Announcements

11.03.2016

Appendix 4D and Half Year Report

2016 Announcements

19.02.2016

CLINUVEL brief on European commercialisation

2016 Announcements

13.02.2016

SCENESSE® receives US FDA orphan designation for cutaneous porphyrias

2016 Announcements

10.02.2016

Presentation to international porphyria patient group

2016 Announcements

07.02.2016

Appendix 4C – Q2 FY16

2016 Announcements

28.01.2016

Form 604

2016 Announcements

25.01.2016

CEO Brief – January 20, 2016

2016 Announcements

20.01.2016

Form 604

2016 Announcements

18.01.2016

.

Go To Top